CEO, UniQuest

Dr Dean Moss

Roles

Role	Organisation	Sources
CEO	UniQuest	Mirage News, Startup Daily (Mon 25 Aug 2025), Business News Australia, materresearch.org.au, @AuManufacturing (Tue 4 Mar 2025), Startup News (WA), Startup Daily (Wed 28 Sep 2022), SmartCompany, @AuManufacturing (Tue 27 Sep 2022), Startup Daily (Tue 5 Apr 2022)

Coverage

Stories naming Dr Dean Moss. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Accelerator $1.5m

Vaccine Platform Secures Funds Against Mosquito Threats

UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.

Mirage News Mon 21 Sep 2026 Proboxis Biotechnology Medical Research Future Fund QIMR Berghofer UniQuest University of Queensland Biointelect Venturer Associate Professor Daniel Rawle Associate Professor Jody Peters Professor David Owen Dr Dean Moss Dr Henry de Malmanche Leah Goodman

Seed $2m

Queensland biotech tops up $1 million Seed round with another $2m

Queensland drug developer Lucia Bio added $2 million to its seed round from UniQuest Extension Fund and Uniseed-managed funds, bringing its overall raise to $3 million ahead of a planned Series A.

Startup Daily Mon 25 Aug 2025 Lucia Bio Molecule to Medicine (MTM)Queensland Emory Drug Discovery Initiative UniQuest Extension Fund University of Queensland UniQuest Uniseed Dr Dean Moss Dr Tom McCarthy

Unnamed stage $1m

UQ biotech innovation partnership forges a second startup

UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.

@AuManufacturing Tue 4 Mar 2025 Curlew Bio Lucia Bio Mater Research Institute-UQ Molecule to Medicine Novartis Queensland Emory Drug Discovery Initiative Spinifex Pharmaceuticals Translational Research Institute UniQuest University of Queensland UniQuest Extension Fund Dr Dean Moss Professor Katharina Ronacher Kirsty McCarthy Dr Tom McCarthy

3 deals

Pharma giant Pfizer wins over telehealth startup ResApp Health with $179 million takeover

Pfizer has completed its takeover of ASX-listed telehealth diagnostics company ResApp Health for $179 million, with the article recalling the company's 2015 listing, earlier raises and a Gates Foundation grant.

Startup Daily Wed 28 Sep 2022 ResApp Australian Competition and Consumer Commission Gates Foundation Pfizer UniQuest University of Queensland Dr Dean Moss Professor Deborah Terry Dr Udantha Abeyratne

Exit / M&A

Pfizer acquires UQ spinout for $179 million

Pfizer has completed its purchase of Brisbane digital health company ResApp Health for $179 million, doubling its per-share offer after an April bid for the ASX-listed cough-diagnosis startup.

@AuManufacturing Tue 27 Sep 2022 Gates Foundation Pfizer ResApp UniQuest University of Queensland Dr Dean Moss Dr Udantha Abeyratne

Also SmartCompany·Startup Daily·Startup Daily·Techboard·Startup News (WA)·sharecafe.com.au

Something wrong? Tell us